High levels of SNAI1 in cancer are associated with downregulation of E-cadherin expression, consequent activation of the Wnt/β-catenin pathway, and the acquisition of an aggressive tumor phenotype [35]. The gene discussed is SNAI1; the disease is neoplasm.